N-propan-2-yl-5-[3-(4-pyridin-2-yl-1H-pyrrolo[3,2-c]pyridin-2-yl)-1H-indazol-5-yl]pyridin-3-amine
C27H23N7 — CID 137114213
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-propan-2-yl-5-[3-(4-pyridin-2-yl-1H-pyrrolo[3,2-c]pyridin-2-yl)-1H-indazol-5-yl]pyridin-3-amine
N-propan-2-yl-5-[3-(4-pyridin-2-yl-1H-pyrrolo[3,2-c]pyridin-2-yl)-1H-indazol-5-yl]pyridin-3-amine (PubChem CID 137114213) has the molecular formula C27H23N7 and a molecular weight of 445.53 g/mol. Its IUPAC name is N-propan-2-yl-5-[3-(4-pyridin-2-yl-1H-pyrrolo[3,2-c]pyridin-2-yl)-1H-indazol-5-yl]pyridin-3-amine.
Molecular Properties
| Compound Name | N-propan-2-yl-5-[3-(4-pyridin-2-yl-1H-pyrrolo[3,2-c]pyridin-2-yl)-1H-indazol-5-yl]pyridin-3-amine |
|---|---|
| PubChem CID | 137114213 |
| Molecular Formula | C27H23N7 |
| Molecular Weight | 445.53 g/mol |
| Exact Mass | 445.20 |
| IUPAC Name | N-propan-2-yl-5-[3-(4-pyridin-2-yl-1H-pyrrolo[3,2-c]pyridin-2-yl)-1H-indazol-5-yl]pyridin-3-amine |
| SMILES | CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccn6)nccc5[nH]4)c3c2)c1 |
| InChI | InChI=1S/C27H23N7/c1-16(2)31-19-11-18(14-28-15-19)17-6-7-23-20(12-17)27(34-33-23)25-13-21-22(32-25)8-10-30-26(21)24-5-3-4-9-29-24/h3-16,31-32H,1-2H3,(H,33,34) |
| InChIKey | BRXWEZXTXABTQV-UHFFFAOYSA-N |
| XLogP | 6.05 |
| TPSA | 95.17 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 445.53 |
| LogP ≤ 5 | 6.05 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137114213 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.